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The recent identiﬁcation of c-kit-positive cardiac stem cells revealed the great growth
reserve of the heart, in which connection among cells might be essential in regulating
their fate. Especially, the mircrine mechanism, translocation of microRNAs (miRs) from a
cell to another via gap junctions, appeared to be important in controlling the differentiation
of cardiac stem cells.The modiﬁcation on miR expression and/or translocation may be able
to enhance further the clinical efﬁcacy of cellular therapy.
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INTRODUCTION
The heart had been considered post-mitotic and terminally dif-
ferentiated. However, the identiﬁcation of resident c-kit-positive
cardiac stem cells in the adult mammalian heart, especially in
humans (Bearzi et al., 2007), has challenged this long-lasting
dogma; the myocardium turned out to be continuously and
dynamically renewed by the activation, migration, and differen-
tiation of the stem cell compartment (Kajstura et al., 2010). In
general, tissue stem cells are stored in a specialized structure called
“niche” and protected from external unfavorable stimuli (Fuchs
et al., 2004). In the human heart, cardiac stem cells exist in the
interstitial spaces among matured cardiomyocytes, namely “car-
diac niches” (Figure 1A), where the primitive cells form gap and
adherens junctions with surrounding myocytes and ﬁbroblasts
(Figures 1B,C) that function as supporting cells in the structure
(Bearzi et al., 2007).
MYOCARDIAL REGENERATION BY CARDIAC STEM CELLS
When c-kit-positive human cardiac stem cells are injected to the
area close to the infarctedmyocardiumof immunosuppressed rats,
muscles and vessels are regenerated improving signiﬁcantly the
ventricular function (Bearzi et al., 2007). In a detailed observa-
tion, gap junctions are formed between the newly formed human
cardiomyocytes and pre-existing rat myocytes (Figure 1D). This
connection should be responsible for the functional integrity of
the regenerated tissue, in which arrhythmia is hardly inducible
(Goichberg et al., 2011) in spite of the variance in size among
human and rat cells.
Although the number of the regenerated cardiomyocytes may
exceed that of the lost muscle cells of the host (D’Amario et al.,
2011), those found in the infarcted area are usually small and
resemble fetal or neonatal myocytes. Meanwhile, stem cells even-
tually engrafted and differentiated in the remote and surviving
regions may mature in a short-term and become indistinguishable
from the surrounding myocytes (Dawn et al., 2005). Together with
the fact that the differentiation of stem cells gets promoted upon
co-culture with parenchymal cells, it implies as if the presence of
fully matured cardiomyocytes next to the committed stem cells
is fundamental for the progressive maturation of the primitive
population.
RNA INTERFERENCE BY microRNAs
MicroRNAs (miRs) are a class of small non-coding RNAs that
are evolutionally well-conserved and negatively regulate gene
expression by repressing protein translation and/or by promot-
ing mRNA degradation. These short RNAs are not uniformly
distributed in the organism but show a preferential localization
that is organ and cell speciﬁc. One miR is considered to tar-
get hundreds of mRNA, whereas one mRNA is interfered by
multiple miRs; this complex network is regulating numerous
biological processes including development, propagation, speci-
ﬁcation, and senescence. In the cardiovascular system, the roles
of many miRs have been disclosed (Small et al., 2010), and
among them, microRNA-499 (miR-499) is barely detectable in
c-kit-positive cardiac stem cells while cardiac myocytes express
at a high level (Hosoda et al., 2011) together with other miRs
such as miR-1 and miR-133. This distinctive distribution may
indicate its importance in the specialization process of cardiomy-
ocytes.
As for the targets of miR-499, genes involved in differenti-
ation, SOX6 and PTBP3 hold in their 3′-untranslated regions
(3′-UTRs) well-conserved miR-499 binding sequences. In fact,
whereas the transcripts of these genes are abundant in cardiac
stem cells and cardiomyocytes, the corresponding protein expres-
sions are minimal only in the myocyte compartment (Hosoda
et al., 2011) suggesting the translational inhibition of SOX6 and
PTBP3 genes by miR-499. This interaction was further conﬁrmed
by the in vitro reporter system; 3T3 ﬁbroblasts, which do not
possess miR-499, were transfected with plasmids overexpressing
miR-499 together with reporter plasmids in which the 3′-UTRs
of SOX6 and PTBP3 were respectively ligated downstream of the
luciferase coding sequence. The luciferase activity decreased in
a dose-dependent manner (Hosoda et al., 2011) suggesting that
these two genes are actual targets of miR-499.
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FIGURE 1 | Niches in the normal human heart (Bearzi et al., 2007).
(A) c-kit-positive human cardiac stem cells (green) are clustered in
interstitial spaces ﬁlled with ﬁbronectin. Arrows in (A) deﬁne the areas in
(B,C). (B,C) At a higher magniﬁcation, gap (connexin 43: Cx43, white) and
adherens (N-cadherin: N-cadh, magenta) junctions are detected between
stem cells (green) and supporting cell, i.e., myocytes (red) and ﬁbroblasts
(*). (D) Connexin 43 (Cx43, yellow) is present between regenerated human
myocytes (red; Alu, green) and spared rat myocytes (red; Alu-negative). See
inset for a higher magniﬁcation.
THE MIRCRINE PHENOMENON
When rat neonatal myocytes, serving as the “donor” cells, and
enhanced green ﬂuorescent protein (EGFP)-labeled human car-
diac stem cells, representing the “recipient” cells, were co-cultured
for 36 h, in situ hybridization revealed miR-499 appearing in 35%
of the recipient cells; in the presence of the gap junction inhibitor,
however, the percentage decreased to less than half (Hosoda et al.,
2011). At the interface of these two types of cells, connexin 43
was detected implicating potential translocation of miR-499 via
gap junction channels. The amount of miR-499 in cardiac stem
cells after 5 days of co-culture measured by quantitative RT-PCR
was ∼200-times more than that of those cultured alone (Hosoda
et al., 2011). However, the exposure of stem cells to the medium
obtained from myocyte cultures failed to increase miR-499 expres-
sion further documenting the necessity of the direct contact of
these cells.
In order to visualize the translocation of miRs, ﬂuorochrome
Cy3-labeledmiR-499was synthesized andmicroinjected to human
cardiac stem cells in culture. Under the microscopic observa-
tion, the ﬂuorescent dye was transferred from the injected cell
to the neighboring cells (Hosoda et al., 2011). More impor-
tantly, miR-499-overexpressing human cardiac stem cells con-
sidered as the “donor” was co-cultured with those expressing
luciferase conjugated to the 3′-UTR of SOX6 serving as the
“recipient.” After 3 days, the luciferase activity was attenuated by
40%, which was prevented by adding the gap junction inhibitor
(Figure 2A; Hosoda et al., 2011). These data clearly demonstrate
the preserved function of the translocated miRs as well as the
dependency on gap junctions. This new modality of cell-to-cell
communication, different from paracrine, was termed “mircrine”
(Figure 2B).
miR-499 AND THE CARDIAC STEM CELL FATE
By overexpressing miR-499 in cardiac stem cells, the amount of
SOX6 and PTBP3 proteins decreases. This modiﬁcation is accom-
panied by augmented differentiation of the cells into myocyte
lineage as documented by the expression of myocyte-speciﬁc anti-
gensNKX2-5 andGATA4. Additionally, the introduction of siRNA
against SOX6 and PTBP3 genes, respectively, enhances similarly
the myocytic commitment, which indicates the function of miR-
499 through SOX6 and PTBP3 inhibitions (Hosoda et al., 2011).
When infarcted ratmyocardium received infusion of c-kit-positive
FIGURE 2 | (A)The repressive activity of translocated miR-499 (miR) on the
3′-untranslated region of SOX6 gene is abolished by the gap junction inhibitor
(+α-GA). Blank indicates donor cells transfected with empty plasmid.
*P < 0.05 vs. blank; **P < 0.05 vs. miR. (B) Schematic representation of the
“mircrine” mechanism: the translocation of miRs from a donor cell to a
recipient cell via gap junctions.
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human cardiac stem cells overexpressing miR-499, the size of the
regenerated human cardiomyocytes was larger and more matured
compared to that found in the heart treatedwithnaive cardiac stem
cells. Both treated hearts showed improved cardiac function than
untreated, but the one with miR-499 overexpression experienced
a greater therapeutic effect (Hosoda et al., 2011).
CLOSING REMARKS
Recently, c-kit-positive cardiac stem cells were used clinically. In
this SCIPIO trial, autologous stem cells were infused into the coro-
nary artery bypass graft (CABG) vessels of the severe heart failure
patients 4 months after the operation. Compared with the con-
trol group treated with bypass surgery only, the cellular therapy
resulted in the remarkable augmentation of cardiac performance
accompanied by the improved symptom (Bolli et al., 2011). All 20
patients were successfully treated without jeopardizing patients’
safety (Chugh et al., 2012). In the future, by modifying miR-
499 expression and/or translocation, the cardiac stem cell therapy
could be advanced. Moreover, the mircrine mechanism might be
operable in controlling the fate of various cells in different organs.
Further investigations and progresses are expected in the ﬁeld.
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